Top Markets
#1 PulseChain PulseChain +43.68%
#2 Fake World Assets Fake World Assets +11.07%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.67%
#4 eCash eCash +5.34%
#5 Meteora Meteora +5.19%
#6 Bitcoin SV Bitcoin SV +4.70%
#7 SkyAI SkyAI +3.89%
#8 EthereumPoW EthereumPoW +3.72%
#9 Shuffle Shuffle +3.61%
#10 Casper Network Casper Network +3.06%
Coin of the day
PulseChain PulseChain
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rangering i aksjer #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aksjekurs
$1.05
Sist synkronisert: 2026-08-19
Markedsverdi
$25.12M
Endring (1 dag)
0.00%
Endring (1 år)
-86.33%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Kategori

Healthcare
Inntekter for Actuate Therapeutics Inc (ACTU)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Actuate Therapeutics Inc er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Actuate Therapeutics Inc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH